Venous thromboembolism in benign esophageal surgery patients: potential cost effectiveness of Caprini risk stratification

[1] Heit JA(2016)The epidemiology of venous thromboembolism J Thromb Thrombolysis 41 3-14

[2] Spencer FA(2015)Review of the cost of venous thromboembolism Clinicoecon Outcomes Res 7 451-462

[3] White RH(2007)Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations J Manag Care Pharm 13 475-486

[4] Fernandez MM(2012)Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published correction appears in Chest. 2012 May;141(5):1369] Chest 141 e227S-e277S

[5] Hogue S(2011)Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients J Am Coll Surg 212 105-112

[6] Preblick R(2010)A validation study of a retrospective venous thromboembolism risk scoring method Ann Surg 251 344-350

[7] Kwong WJ(2014)Reducing postoperative venous thromboembolism complications with a standardized risk-stratified prophylaxis protocol and mobilization program J Am Coll Surg 218 1095-1104

[8] Spyropoulos AC(2014)Validation of a venous thromboembolism risk assessment model in gynecologic oncology Gynecol Oncol 134 160-163

[9] Lin J(2018)Caprini risk model decreases venous thromboembolism rates in thoracic surgery cancer patients Ann Thorac Surg 105 879-885

[10] Gould MK(2010)Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review Pharmacoeconomics 28 521-538

[1] Heit JA(2016)The epidemiology of venous thromboembolism J Thromb Thrombolysis 41 3-14

[2] Spencer FA(2015)Review of the cost of venous thromboembolism Clinicoecon Outcomes Res 7 451-462

[3] White RH(2007)Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations J Manag Care Pharm 13 475-486

[4] Fernandez MM(2012)Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published correction appears in Chest. 2012 May;141(5):1369] Chest 141 e227S-e277S

[5] Hogue S(2011)Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients J Am Coll Surg 212 105-112

[6] Preblick R(2010)A validation study of a retrospective venous thromboembolism risk scoring method Ann Surg 251 344-350

[7] Kwong WJ(2014)Reducing postoperative venous thromboembolism complications with a standardized risk-stratified prophylaxis protocol and mobilization program J Am Coll Surg 218 1095-1104

[8] Spyropoulos AC(2014)Validation of a venous thromboembolism risk assessment model in gynecologic oncology Gynecol Oncol 134 160-163

[9] Lin J(2018)Caprini risk model decreases venous thromboembolism rates in thoracic surgery cancer patients Ann Thorac Surg 105 879-885

[10] Gould MK(2010)Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review Pharmacoeconomics 28 521-538